Market Overview

6 Reasons Why Coty Is No Longer A Buy At BMO

6 Reasons Why Coty Is No Longer A Buy At BMO
Benzinga's Top Upgrades, Downgrades For January 4, 2019
Benzinga's Top Upgrades, Downgrades For November 15, 2018

Beauty company Coty Inc (NYSE: COTY) reported fiscal fourth-quarter earnings Monday that prompted BMO Capital Markets to downgrade the stock on fears the company will miss its fiscal 2019 guidance.  

The Analyst

BMO's Shannon Coyne downgraded Coty from Outperform to Market Perform with a price target lowered from $18 to $12.

The Thesis

Coty guided its fiscal 2019 EPS to a range of 74-78 cents in its earnings report, but six factors suggest the company may fall short of its estimates, Coyne said in the downgrade note. (See the analyst's track record here.) 

They are: 

  • Supply chain disruptions seen in Q4 may take longer to fix and make it difficult to determine the health of the company versus transitory execution problems.
  • The overall mass beauty market in the U.S. is declining by a low single-digit rate, but new independent brands are gaining share.
  • Coty still needs to clear out old inventory and is doing so through increased promotions, and a full reset with new packaging isn't expected until December.
  • Management said it will re-invest $90 million from a $150-million cost saving initiative, but this figure is likely to come in higher.
  • Traction is being seen with beauty influencers but is unlikely to reap any notable benefits until the second half of the fiscal year.
  • Debt levels remain high, with a current net debt/adjusted EBITDA multiple of 5.27 times. The figure should improve to 4 times by 2020, but still gives management minimal options for accretive M&A deals.

Price Action

Coty shares were trading up 2 percent to $11.75 at the time of publication Wednesday. 

Related Links:

Coty Q4 Earnings Preview

Deutsche Bank: 4 Reasons Why Coty's Stock Is No Longer Attractive

Latest Ratings for COTY

Jan 2019JP MorganUpgradesUnderweightNeutral
Nov 2018BMO CapitalUpgradesMarket PerformOutperform
Nov 2018Morgan StanleyDowngradesEqual-Weight

View More Analyst Ratings for COTY
View the Latest Analyst Ratings

Posted-In: Beauty Beauty Products BMO Capital Markets Shannon CoyneAnalyst Color Downgrades Price Target Analyst Ratings Best of Benzinga


Related Articles (COTY)

View Comments and Join the Discussion!

Latest Ratings

EMNMorgan StanleyUpgrades90.0
DERMRaymond JamesUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Argenx Shares Up After AbbVie Exercises Option To License Immuno-Oncology Drug

Janney: Nightstar Therapeutics Has 'Significant Upside Potential' With Retinal Disorder Treatments